Results 1 to 10 of about 40,505 (187)

Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients [PDF]

New England Journal of Medicine, 2011
The efficacy and safety of prolonging prophylaxis for venous thromboembolism in medically ill patients beyond hospital discharge remain uncertain. We hypothesized that extended prophylaxis with apixaban would be safe and more effective than short-term ...
Jeffrey I Weitz
exaly   +5 more sources

A Case of an Allergic Contact Dermatitis Following the Administration of Enoxaparin: A Case Report and Review of the Literature [PDF]

Clinical Medicine Insights: Case Reports
Introduction: Allergic contact dermatitis (ACD) is a rare but clinically significant hypersensitivity reaction to certain medications, including enoxaparin, a commonly used low-molecular-weight heparin (LMWH) for venous thromboembolism (VTE) prophylaxis.
Hend M. Alotaibi, Alhanoof Alajlan, Abdulrahman Alluhaybi, Ahmed A. Alhumidi   +3 more
doaj   +2 more sources

Comparative efficacy of certoparin, enoxaparin, and combined thromboprophylaxis on thromboembolic events after glioblastoma resection: a prospective observational study [PDF]

Scientific Reports
Thromboembolic events (TE) are serious complications following glioblastoma (GBM) resection. This retrospective study analyzed 695 GBM patients (2017–2022, University Hospital Dresden) to assess the impact of different anticoagulant regimens—certoparin ...
Eva Wardenbach, Dino Podlesek, Boshr Alhasan, Ahmed Abouelhamd, Ilker Y. Eyüpoglu, Tareq A. Juratli, Witold H. Polanski   +6 more
doaj   +2 more sources

Biosimilar versus branded enoxaparin to prevent postoperative venous thromboembolism after surgery for digestive tract cancer: Randomized trial.

PLoS ONE, 2023
Cancer and/or major surgery are two factors that predispose to post-operative thrombosis. The annual incidence of venous thromboembolic disease (VTED) in cancer patients was estimated at 0.5%-20%.
Chadli Dziri, Wafa Ben Hmida, Wejih Dougaz, Mehdi Khalfallah, Imen Samaali, Hichem Jerraya, Ibtissem Bouasker, Ramzi Nouira   +7 more
doaj   +1 more source

Admission thrombelastography does not guide dose adjustment of enoxaparin in trauma patients

Surgery Open Science, 2020
Background: Enoxaparin is used as chemoprophylaxis to reduce incidence of venous thromboembolism and its complications following trauma. Serum anti-Xa monitoring is used to assess efficacy but requires several doses to be administered. Thrombelastography
Hannah V. Hayes, Molly E. Droege, Craig J. Furnish, Michael D. Goodman, Neil E. Ernst, Christopher A. Droege   +5 more
doaj   +1 more source

Extended thromboprophylaxis with betrixaban in acutely ill medical patients [PDF]

, 2016
BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown.
. Lodigiani, M, : W. Ageno, I, Cerveri, A., Cohen, Alexander T, De Pellegrin, D, D’Angelo, A, Gibson, C. Michael, Gold, Alex, Goldhaber, Samuel Z., Harrington, Robert A., Hernandez, Adrian F., Hull, Russell D., Imberti, R., Investigators, Italy (261 patients, 19 sites, Landolfi, G, LEMBO, Giuseppe, Luisetti, M., Wiens, Brian L.   +18 more
core   +7 more sources

Development of Lipid–Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin

Pharmaceutics, 2020
Enoxaparin, an anticoagulant that helps prevent the formation of blood clots, is administered parenterally. Here, we report the development and evaluation of lipid–polymer hybrid nanoparticles (LPHNs) for the oral delivery of enoxaparin.
Bo Tang, Yu Qian, Guihua Fang
doaj   +1 more source

Cell-Penetrating Peptide-Surface Modified Liposomes to Enhance the Intestinal Absorption of Enoxaparin [PDF]

Pharmaceutical Sciences, 2023
Background: Enoxaparin is low-molecular-weight heparin administered by subcutaneous/intravenous injection. The oral bioavailability of enoxaparin is restricted by its low absorption through the intestine.
Hessam Rostamian, Hadi Valizadeh, Mohammad Mahmoudian, Ziba Islambulchilar, Parvin Zakeri-Milani   +4 more
doaj   +1 more source

The effects of enoxaparin on the liver in experimental pneumoperitoneum model [PDF]

Acta Cirúrgica Brasileira, 2016
PURPOSE: To investigate the potential protective effects of enoxaparin against the adverse events of carbon dioxide (CO2) pneumoperitoneum. METHODS: Thirty four rats were divided into three groups: Group 1 (sham) underwent insertion of Veress needle ...
Turgut Cavusoglu, Kemal Kismet, Namik Ozcan, Berkay Kucuk, Aziz Mutlu Barlas, Bahadir Osman Bozkirli, Pinar Celepli, Mehmet Senes, Serkan Bolat, Sema Hucumenoglu   +9 more
doaj   +2 more sources

The Impact of Continuous Veno-Venous Hemodiafiltration on the Efficacy of Administration of Prophylactic Doses of Enoxaparin: A Prospective Observational Study

Pharmaceuticals, 2023
Background: Critically ill patients frequently require continuous renal replacement therapy (CRRT). During CRRT, particles up to 10 kDa in size, such as enoxaparin, may be removed. The aim of this study was to determine if patients receiving prophylactic
Aleksander Aszkiełowicz, Karol P. Steckiewicz, Michał Okrągły, Magdalena A. Wujtewicz, Radosław Owczuk   +4 more
doaj   +1 more source